Bellwether Investment Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$532K Buy
15,486
+187
+1% +$6.38K 2.13% 14
2017
Q3
$518K Buy
15,299
+450
+3% +$14.5K 2.43% 10
2017
Q2
$473K Buy
14,849
+498
+3% +$15.7K 2.19% 14
2017
Q1
$466K Sell
14,351
-9,454
-40% -$298K 1.23% 13
2016
Q4
$734K Buy
+23,805
New +$727K 0.66% 26
2016
Q2
$371K Buy
+11,107
New +$354K 0.41% 69

Other funds holding PFE

Bellwether Investment Group's PFE Position: Q4 2017 in Review

Bellwether Investment Group increased its Pfizer (PFE) stake by 1.2% in Q4 2017, buying an estimated $6.38K and bringing the position to 15,486 shares worth $532K. The position accounts for 2.13% of the portfolio, ranked #14.

Bellwether Investment Group first reported a position in PFE in Q2 2016 and has held it in 6 quarters since. The position peaked at $734K in Q4 2016. 2,244 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Bellwether Investment Group held 15,486 shares of Pfizer worth $532K as of Q4 2017.
  • Bellwether Investment Group bought 187 Pfizer shares in Q4 2017, an estimated $6.38K.
  • Pfizer made up 2.13% of Bellwether Investment Group's portfolio in Q4 2017, its #14 holding.
  • Bellwether Investment Group first reported a position in Pfizer in Q2 2016 and has held it in 6 quarters since.
  • Bellwether Investment Group's Pfizer position peaked at $734K in Q4 2016.
  • 2,244 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Bellwether Investment Group's 13F filing for Q4 2017, filed 30 Jan 2018.